Company Performance: Sanofi's financial results, including revenue, profit margins, and earnings per share, strongly influence investor sentiment and stock value.

Pharmaceutical Pipeline: The success rate and potential market value of Sanofi's drug development pipeline are crucial, as new product launches drive future growth.

Regulatory Approvals: Approvals or rejections of Sanofi's drugs by regulatory agencies like the FDA or EMA significantly impact investor confidence and stock price.

Market Competition: Competitive pressures from other pharmaceutical companies, including pricing strategies and new drug introductions, can affect Sanofi's market share and profitability.

Economic Conditions: Overall economic health, including inflation, interest rates, and GDP growth, affects investment decisions and the attractiveness of stocks like SSFO34.SA.

Currency Exchange Rates: Fluctuations in the exchange rate between the Brazilian Real and other currencies can impact the value of SSFO34.SA, as it represents a share in a foreign company.

Global Health Trends: Pandemics, emerging diseases, and changes in healthcare practices can shift demand for Sanofi's products and affect its stock price.

Investor Sentiment: General market sentiment and investor risk appetite can influence demand for SSFO34.SA, independent of Sanofi's underlying performance.

Dividend Policy: Sanofi's dividend payouts and dividend yield can attract income-seeking investors and support the stock price.

Legal and Political Factors: Changes in healthcare regulations, intellectual property laws, or political instability can impact Sanofi's operations and stock valuation.